Joint Pain Injections Market to Garner US$ 10.3 Billion Revenue By 2028 Propelled By Significant Increase in Arthritis Cases Globally

The global joint pain injections market size is estimated to witness growth at a CAGR of 8.2% during the forecast period from 2021 to 2028 and reach the market value of US$ 10.3 Billion by 2028, as per the recently published report by Acumen Research And Consulting.

The main factor propelling the worldwide joint pain injections market revenue is the increased prevalence of joint pain situations in different parts of the world. In addition, one of the biggest trends in the market for joint pain injections is the rise in cases of arthritis. Joint pain is characterized as discomfort in any joint of the body. Joint discomfort is a frequent complaint. There are numerous diseases and disorders that can lead to joint discomfort. A person with polyarthralgia has pain in several joints at once. Pain in the joints is frequently brought on by a sickness, injury, infection, or inflammation.

Get a Free Sample of Report@

https://www.acumenresearchandconsulting.com/request-sample/1352

Joint Pain Injections Market Report Coverage:

 COVID-19 Impact on Joint Pain Injections Market Value

The Covid-19 outbreak is probably going to hurt sales of joint pain injections worldwide. The COVID-19 pandemic illness in 2020 decreased sales in the market for joint pain injections. Due to resource movement and supply chain disruptions, revenue has decreased. During the pandemic, non-COVID cases and elective procedures were postponed due to the rise of COVID-19 illness patients.

Joint Pain Injections Industry

Joint pain injections market size is influenced by a number of variables, including an ageing population, sedentary lifestyles, and an increase in obesity occurrences. Furthermore, two current market trends for joint pain injections are driving the sector forward: rising technology development and a growing government focus on patient care.

However, the market expansion is being hampered by a dearth of medical personnel and a lack of knowledge regarding these injections, particularly in developing nations. Furthermore, the market is anticipated to increase in the next years due to rising hyaluronic acid injection demand and new product advancements from major players.

Check the detailed table of contents of report @

https://www.acumenresearchandconsulting.com/table-of-content/joint-pain-injections-market

Growing Arthritis Cases Across the Globe

One of the most likely reasons for joint pain is arthritis. The two most prevalent kinds of arthritis are rheumatoid arthritis (RA) and osteoarthritis (OA) (RA). According to the American College of Rheumatology, OA is more prevalent in people over the age of 40. Osteoarthritis has a disproportionately negative impact on the elderly. It is the main contributor to impairment among elderly people worldwide. Indicative osteoarthritis affects 9.6% of men and 18% of women over 60 worldwide, according to the World Health Organization (WHO). Osteoarthritis patients have movement restrictions in 80% of cases, and 25% of them are unable to carry out their main daily tasks. With a prevalence ranging from 22 percent to 39 percent, osteoarthritis is the second most prevalent rheumatologic condition and the most common joint illness in India. OA affects women more frequently than it does males. 70 percent of women with radiological evidence of OA and 45 percent of women with symptoms over the age of 65.

Joint Pain Injections Market Segmentation

The global joint pain injections market is categorized into: joint type, type, distribution channel, and region.

Joint Pain Injections Market By Joint Type

• Hip Joint
• Knee and Ankle
• Face Joints of the Spine
• Shoulder and Elbow

The knee and ankle sub-segment outperformed all other joint types in 2021 and is projected to continue to do so going forward. The rising incidence of knee osteoarthritis is to blame for the rising demand for intra-articular injections for the treatment of knee discomfort. In research released by the National Center for Biotechnology Information in 2020, it was found that the prevalence of knee osteoarthritis (OA) was 22.9 percent in adults over 40 and was 16.0% in those over the age of 15 worldwide.

Joint Pain Injections Market By Type

• Hyaluronic Acid Injections
• Corticosteroid Injections
• Other

While the hyaluronic acid injections sub-segment is anticipated to increase at the quickest rate over the next few years, the corticosteroid injections sub-segment held a sizable market share in 2021. Injections of hyaluronic acid are most frequently used to alleviate osteoarthritis-related knee discomfort. These injections are used if corticosteroids do not effectively reduce pain.

Joint Pain Injections Market By Distribution Channel

• Online Pharmacies
• Hospital Pharmacies
• Retail Pharmacies

Our analysis of the joint pain injections market showed that hospital pharmacies held the largest share of the market from 2021 to 2028. The domination of hospital pharmacy can be linked to the increasing number of orthopedic patients being admitted to hospitals worldwide. On the other hand, it is anticipated that the internet distribution channel segment will expand more quickly than the other sub-segment.

Buy this premium research report –

https://www.acumenresearchandconsulting.com/buy-now/0/1352

Joint Pain Injections Market Regional Outlook

Injections for joint pain are sold throughout Europe, the Asia-Pacific region, North America, Latin America, the Middle East, and Africa. North America is anticipated to have the largest market share over the coming few years. The market share for joint pain injections is primarily driven by the rising number of OA patients. In the United States, 31 million people suffer from osteoarthritis. The incidence of symptomatic knee OA is approximately 10% in males and 13% in women, according to the research study. In 2010, around 720,000 complete knee arthroplasties were performed in the US. Due to a growth in ageing populations, greater awareness of joint pain in Asian nations like India, and high levels of visco-supplementation acceptance in Japan, the Asia Pacific market is anticipated to expand at a considerable CAGR over the course of the projected period.

Joint Pain Injections Market Players

Some of the market players profiled in the report include Chugai Pharmaceutical Co., Ltd., Anika Therapeutics, Inc., Bioventus, Ferring B.V., Sanofi, Allergan Plc., Flexion Therapeutics, Inc., SEIKAGAKU CORPORATION, Pfizer Inc., and Zimmer Biomet Holdings, Inc.

Browse More Research Topic on Healthcare Sector:

The global pain management market size is expected to witness growth at a CAGR of 6.5% during the forecast period from 2020 to 2027 and reach the market size of US$ 65.8 Billion by 2027.

The global hepatitis B vaccine market size is slated to reach the market value of US$ 2,136.7 Million by 2026, growing at a CAGR of 5.8% during the period from 2019 to 2026.

The global varicose vein treatment devices market size is projected to witness CAGR of 6.9% during the period from 2021 to 2028 and reach the market size of US$ 1,812.6 Million by 2028.

For Latest Update Follow Us on Twitter and, LinkedIn

Contact Us:

Mr. Richard Johnson

Acumen Research and Consulting

USA: +1 347 474 3864

India: +91 8983225533

E-mail: sales@acumenresearchandconsulting.com